Principal TechnologiesTSXV:PTEC 22 Market Cap is C$20.17 Mil as of Jul. 02, 2026. GuruFocus rates TSXV:PTEC with a GF Score™ of 22/100 and a GF Value™ of C$0.03 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Principal Technologies ranks worse than 78.85% on this metric.
Principal Technologies's quarterly market cap
increased
from Jul. 2025 (C$10.37 Mil) to Oct. 2025 (C$13.58 Mil) and
increased
from Oct. 2025 (C$13.58 Mil) to Jan. 2026 (C$30.26 Mil).
Principal Technologies's annual market cap
increased
from Jul. 2023 (C$2.97 Mil) to Jul. 2024 (C$5.53 Mil) and
increased
from Jul. 2024 (C$5.53 Mil) to Jul. 2025 (C$10.37 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Principal Technologies's Enterprise Value for Today is C$20.33 Mil.
Principal Technologies (TSXV:PTEC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:PTEC vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, Principal Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Principal Technologies Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Principal Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Principal Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Principal Technologies's Market Cap for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Principal Technologies (TSXV:PTEC) has a Market Cap of C$20.17 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Principal Technologies and its competitors. According to the industry distribution chart, Principal Technologies ranks #548 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 78.8%.
Is Principal Technologies' Market Cap too high?
Principal Technologies' current Market Cap is C$20.17 Mil. Based on the distribution chart, Principal Technologies ranks #548 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Principal Technologies has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Principal Technologies' Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Principal Technologies ranks #548 out of 695 companies for Market Cap. This places Principal Technologies in the lower half of its industry. The industry median Market Cap is 96.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 96.57, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Principal Technologies and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 96.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Principal Technologies's current Market Cap is C$20.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Principal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Principal Technologies (TSXV:PTEC) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.03, compared to a current price of C$0.38 — trading 1166.7% above its estimated fair value. The current Market Cap is C$20.17 Mil. Principal Technologies' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Principal Technologies (TSXV:PTEC), the current Market Cap is C$20.17 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Principal Technologies (TSXV:PTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Principal Technologies stock appears to be overvalued.
The current stock price of C$0.38 is trading 1166.7% above its estimated GF Value™ of C$0.03.
GuruFocus considers Principal Technologies to be Significantly Overvalued.
Key valuation signals for TSXV:PTEC:
Market Cap: C$20.17 Mil
GF Value™: C$0.03 vs. price of C$0.38 (1166.7% above fair value)
No single metric tells the full story. See the TSXV:PTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Principal Technologies Inc is in the research and development stage of building a portfolio of medical technology assets with a focus on distribution potential and intellectual property capable of enhancing medical treatment, cost efficiency, and optimization of the patient pathway. The company focuses on acquiring medical technology research and development assets or developing them jointly with industry leaders. Its current revenue-generating activities are attributable to E&E CRO Consulting GmbH, which provides clinical research advisory services. The company operates in one reportable operational segment, consisting of project management of clinical studies and research related to medical device technologies.
22GF Score
Get the complete analysis for TSXV:PTEC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PTEC has been successfully added to your 
